Management of coronary artery disease (CAD) in patients with severe aortic stenosis (AS)
referred for transcatheter aortic valve replacement (TAVR) is posing challenges. Due to …

Aims: To describe the characteristics of coronary artery disease (CAD) in high-risk patients
with aortic stenosis (AS), and its impact on indications for transcatheter aortic valve …

Aims: Coronary artery disease (CAD) is frequently present in patients with severe aortic
stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI). While …

Background: Transcatheter aortic valve replacement (TAVR) is now the standard of care for
patients with symptomatic severe aortic stenosis who are extreme, high, or intermediate risk …

Objectives: This study sought to assess in patients undergoing transcatheter aortic valve
implantation (TAVI), the prevalence and impact of incomplete coronary revascularization …

Transcatheter aortic valve replacement (TAVR) is a viable option in the treatment of severe
aortic stenosis in patients at high risk for surgery. We sought to further investigate outcomes …

Transcatheter aortic valve implantation (TAVI) with the Cribier-Edwards prosthesis may
provide an alternative to conventional aortic valve replacement in high-risk patients with …

Background—The Placement of Aortic Transcatheter Valves (PARTNER) trial demonstrated
similar survival after transcatheter and surgical aortic valve replacement (TAVR and SAVR …

Comparisons of transcatheter aortic valve implantation (TAVI) to surgical aortic valve
replacement (SAVR) in patients with severe aortic stenosis remain sparse or limited by a …

Significant coronary artery disease (CAD) is a frequent finding in patients with severe aortic
stenosis undergoing transcatheter aortic valve implantation (TAVI), and the management of …